Centessa Pharmaceuticals plc (CNTA)
NASDAQ: CNTA · Real-Time Price · USD
22.02
+0.21 (0.94%)
At close: Sep 15, 2025, 4:00 PM EDT
22.29
+0.27 (1.25%)
After-hours: Sep 15, 2025, 4:21 PM EDT

Centessa Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
2,9522,2087772931,012-
Upgrade
Market Cap Growth
72.00%184.18%165.01%-71.03%--
Upgrade
Enterprise Value
2,8201,775579-83433-
Upgrade
Last Close Price
22.0216.757.963.1011.26-
Upgrade
PS Ratio
189.09-113.40---
Upgrade
PB Ratio
8.555.503.290.872.06-
Upgrade
P/TBV Ratio
8.565.503.290.872.06-
Upgrade
EV/Sales Ratio
187.98-84.53---
Upgrade
Debt / Equity Ratio
0.340.290.360.210.151.82
Upgrade
Asset Turnover
0.03-0.02---
Upgrade
Quick Ratio
9.939.107.5110.9724.841.18
Upgrade
Current Ratio
10.129.258.0011.4225.521.30
Upgrade
Return on Equity (ROE)
-72.92%-73.93%-52.79%-52.24%-154.41%-
Upgrade
Return on Assets (ROA)
-28.96%-26.82%-26.61%-24.48%-27.16%-
Upgrade
Return on Capital (ROIC)
-30.88%-29.91%-29.46%-27.01%-30.24%-
Upgrade
Earnings Yield
-7.80%-10.67%-19.44%-73.73%-37.73%-
Upgrade
FCF Yield
-4.88%-6.43%-20.65%-68.77%-13.47%-
Upgrade
Buyback Yield / Dilution
-27.54%-19.02%-2.97%-24.26%-401.11%-
Upgrade
Updated Aug 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q